[
vaccine trial
]
Astrazeneca cleared by US regulators to resume vaccine trial
By Bloomberg| Posted by Susmita Pakrasi | Bloomberg
UPDATED ON OCT 24, 2020 01:59 AM IST
The US Food and Drug Administration authorized the trial to resume Friday, according to statements from AstraZeneca and Oxford. The FDA reviewed data from global studies and decided it was safe to begin testing again, the partners said.
UK seeks non-white volunteers for Covid-19 vaccine trials
By Prasun Sonwalkar | Hindustan Times, London
UPDATED ON OCT 13, 2020 06:08 PM IST
The non-white community has been disproportionately affected by coronavirus pandemic, prompting the government to launch an inquiry. Currently the community is under-represented in six vaccine clinical trials taking place across the UK.
To beat the pandemic, begin mass campaign on safety protocols
By Rakesh Thukral
PUBLISHED ON SEP 28, 2020 07:54 PM IST
Places of congregation, like markets, offices, public transport, slums, and residential areas, must be specially targeted. Just as non-compliance with road safety rules leads to traffic fines and more, there must also be strict emphasis on compliance for the Covid-19 safety protocols.
Covid-19 vaccine: China, UAE report positive results in phase 3 trials | All you need to know
By hindustantimes.com | Edited by Poulomi Ghosh | Hindustan Times, New Delhi
UPDATED ON SEP 16, 2020 02:46 PM IST
The UAE authorities said 31,000 volunteers, representing 125 nationalities have been administered the vaccine during the trial. Apart from mild side-effects, no severe illness has been reported so far.
Scientists, drugmakers and traders react to AstraZeneca’s Covid-19 vaccine trial pause
By Reuters| Posted by Susmita Pakrasi | London
PUBLISHED ON SEP 09, 2020 06:44 PM IST
“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials,” AstraZeneca said in an emailed statement.
AstraZeneca pauses Covid-19 vaccine trial after unexplained illness
By Bloomberg | Posted by Prashasti Singh
UPDATED ON SEP 09, 2020 10:05 AM IST
The pause stemmed from a standard review of the company’s vaccine trials after one person developed an unexplained illness, AstraZeneca said in a statement.
Russian vaccine trials show strong immune response: The Lancet
By Prasun Sonwalkar | Hindustan Times, London
PUBLISHED ON SEP 04, 2020 04:53 PM IST
The two-part vaccine includes two adenovirus vectors – recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S) – which have been modified to express the SARS-CoV-2 spike protein
Covid-19: Health insurance is your best bet against steep medical costs
By Promotional Feature, HT Brand Studio
UPDATED ON AUG 13, 2020 02:29 PM IST
A health insurance policy will not only make it easier for you to get proper medical facilities, but also save you from emptying your financial reservoirs.
Russian hackers targeting vaccine trials, say UK, US, Canada
By Prasun Sonwalkar| Posted by Susmita Pakrasi | Hindustan Times, London
UPDATED ON JUL 16, 2020 08:10 PM IST
The UK centre released a report, revealing IP addresses and other details, adding that similar conclusion has also been reached by Canada’s Communications Security Establishment (CSE) and United States’ National Security Agency (NSA).
Chinese researchers launch phase-2 human test for possible coronavirus vaccine
By Reuters | Beijing
PUBLISHED ON JUN 21, 2020 01:57 PM IST
About a dozen vaccines are in different stages of human tests globally, as the World Health Organization warns the coronavirus pandemic is accelerating and “the world is in a new and dangerous phase”.
Serum Institute investing USD 100 million on potential Covid-19 vaccine
By Press Trust of India | Pune
PUBLISHED ON JUN 09, 2020 09:08 PM IST
At least half a dozen attempts at creating a vaccine against coronavirus are on globally and the efforts at Oxford are considered one of the most promising.
Antibody testing, vaccine trial: What India and the world are doing for Covid-19 vaccine
By hindustantimes.com | Edited by: Amit Chaturvedi | Hindustan Times, New Delhi
UPDATED ON MAY 21, 2020 12:58 PM IST
US President Donald Trump had disclosed on Tuesday that he was taking hydroxychloroquine to keep Covid-19 at bay.